Galderma Group N Shareholders' Equity for the year ending December 31, 2024: USD 7.79 B

Galderma Group N Shareholders' Equity is USD 7.79 B for the year ending December 31, 2024, a 45.23% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Galderma Group N Shareholders' Equity for the year ending December 31, 2023 was USD 5.36 B, a 19.97% change year over year.
  • Galderma Group N Shareholders' Equity for the year ending December 31, 2022 was USD 4.47 B, a -1.58% change year over year.
  • Galderma Group N Shareholders' Equity for the year ending December 31, 2021 was USD 4.54 B.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory